Roivant Sciences's total assets for Q3 2023 were $7.31B, an increase of 254.03% from the previous quarter. ROIV total liabilities were $728.10M for the fiscal quarter, a -1.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.